PanOph
Free previewYou're reading the free part of this topic. The rest is included with Clinical.See what's included

Toxic optic neuropathy

Neuro-Ophthalmology

Key Points

  • •Toxic optic neuropathy presents as bilateral, symmetric, painless, progressive visual loss with cecocentral scotomas and dyschromatopsia - the papillomacular bundle is selectively vulnerable due to high metabolic demand and thin myelination
  • •Ethambutol is the most important drug cause - baseline screening (VA, color vision, visual fields) BEFORE starting treatment and monthly monitoring during use; stop immediately at first sign of toxicity
  • •Methanol poisoning is a medical emergency - metabolized to formic acid which inhibits cytochrome c oxidase; treat with fomepizole (alcohol dehydrogenase inhibitor), hemodialysis, and folate
  • •Color vision loss (Ishihara plates) is often the earliest detectable sign of toxic optic neuropathy - it may precede visual acuity drop and is the key screening tool for ethambutol monitoring
  • •All toxic/nutritional optic neuropathies share a common final pathway of mitochondrial dysfunction - this explains the clinical overlap with LHON (primary mitochondrial DNA defect)

Free preview ends here

Keep reading Toxic optic neuropathy

17 more sections are included with the Clinical plan.

  • Definition
  • Epidemiology
  • Aetiology and causes
  • Pathogenesis
  • Classification
  • Risk factors and associations

Clinical plan

Every Learn topic in full, with oral-exam questions and MCQs.

View plans